DJIA 16,528.03 -114.98 -0.69%
NASDAQ 4,776.51 -51.82 -1.07%
S&P 500 1,972.18 -16.69 -0.84%
market minute promo

230.60 -5.52 (-2.34%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VRX $230.60 -2.34%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $234.66
Previous Close $236.12
Daily Range $228.59 - $237.80
52-Week Range $111.41 - $263.81
Market Cap $79.0B
P/E Ratio 97.17
Dividend (Yield) $0.00 (0.0%)
Volume 1,559,132
Average Daily Volume 1,967,642
Current FY EPS $2.96




Drug Makers

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website:

News & Commentary

The Berkshire Hathaway of Biotech Strikes Again

Valeant Pharmaceuticals adds to its growing portfolio of products with the purchase of Sprout Pharmaceuticals. Find out what's made Valeant such a great stock to own, and what investors should be monitoring going forward.

Novogen (NVGN) Conducts Scientific Review of R&D Program

Acelity Files To Float, But Is It Secretly Seeking A Buyer?

Sequoia Fund Comments on Valeant Pt. II

Sequoia Fund Comments on Valeant Pt. II

This Week In Pharma: Keryx's Sluggish Drug Launch Vs. Excitement At Valeant And Palatin

Insider Trading Alert - VRX, WSTC And CPHD Traded By Insiders

Sucampo to Acquire R-Tech Ueno for About $278 Million

Sequoia Fund Comments on Valeant Pharmaceuticals

Glenn Greenberg Acquires Two New Stakes

Valeant Pharmaceuticals' (VRX) Charts Read Like a Textbook Bull

See More VRX News...

VRX's Top Competitors

VRX $230.60 (-2.34%)
Current stock: VRX
JNJ $93.98 (-1.25%)
Current stock: JNJ
NVS $97.22 (-1.15%)
Current stock: NVS
RHHBY $34.16 (-0.01%)
Current stock: RHHBY